Aardvark Therapeutics, Inc.
AARD
$5.39
$0.020.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.59M | -48.77M | -36.64M | -27.72M | -20.59M |
| Total Depreciation and Amortization | 36.00K | 34.00K | 32.00K | 19.00K | 16.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.03M | 1.81M | 945.00K | 881.00K | 912.00K |
| Change in Net Operating Assets | 356.00K | 1.84M | 2.75M | -465.00K | 1.57M |
| Cash from Operations | -54.17M | -45.09M | -32.91M | -27.29M | -18.09M |
| Capital Expenditure | -95.00K | -101.00K | -102.00K | -104.00K | -109.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.57M | -85.76M | -115.01M | -124.51M | -11.89M |
| Cash from Investing | -49.67M | -85.86M | -115.12M | -124.62M | -12.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 91.64M | 91.53M | 91.52M | 91.52M | 332.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 85.00M | 85.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.39M | -3.56M | -3.67M | -5.65M | -3.34M |
| Cash from Financing | 89.25M | 87.96M | 87.85M | 170.87M | 81.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.59M | -42.99M | -60.18M | 18.96M | 51.91M |